Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

The project created a standardized system for classifying skin lesions in lab rats and mice.

Pregnancy can cause various skin changes, including pigmentation, acne, and stretch marks, and may affect preexisting skin conditions.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Skin symptoms are important for diagnosing infections in children.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Thallium poisoning from contaminated cake caused severe health issues in Baghdad, highlighting the need to ban thallium as a rodenticide.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.